Rachel L Leonardis1, Jacob G Robison, Todd D Otteson. 1. Departments of Otolaryngology, Children's Hospital of Pittsburgh, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania 15224, USA. leonardis.rachel@medstudent.pitt.edu
Abstract
OBJECTIVES: To investigate interventions used in treating obstructive sleep apnea in neonates and infants and to report their efficacies. DESIGN: Retrospective medical record review. SETTING: Tertiary care children's hospital. PATIENTS: Neonates and infants aged 0 to 12 months at the time of obstructive sleep apnea diagnosis by polysomnography. MAIN OUTCOME MEASURES: Demographic data, comorbidities, polysomnography data, and intervention data. RESULTS: In total, 126 patients (86 [68.3%] male and 40 [31.7%] female) were included in the study. The most common interventions (and the mean age at the time of intervention) were anti-gastroesophageal reflux disease treatment (88 patients [69.8%] at age 7 months), observation (33 patients [26.2%] at age 6 months), supplemental oxygen (31 patients [24.6%] at age 4 months), adenoidectomy (30 patients [23.8%] at age 15 months), other surgical (25 patients [19.8%] at age 7 months), continuous positive airway pressure/bilevel positive airway pressure (CPAP/BiPAP) (18 patients [14.3%] at age 16 months), supraglottoplasty (11 patients [8.7%] at age 6 months), tonsillectomy and adenoidectomy (9 patients [7.1%] at age 24 months), tracheostomy (7 patients [5.6%] at age 10 months), and other nonsurgical (7 patients [5.6%] at age 15 months). Among neonates and infants, nonsurgical interventions were performed in most cases, although those aged 0 to 3 months underwent more surgical interventions (19.7%) than those aged older than 3 to 9 months (11.7%). The mean objective improvement, measured as a percentage decrease in preintervention to postintervention apnea-hypopnea index, was greatest in neonates and infants receiving CPAP/BiPAP, followed by those undergoing tracheostomy. CONCLUSIONS: Anti-gastroesophageal reflux disease treatment is the most common intervention in each age group. Although adenoidectomy is the most common surgical intervention overall, the prevalence increases with age. Supraglottoplasty is the most common surgical intervention in neonates and infants aged 0 to 3 months and offers the greatest objective improvement in this age group. Overall, the use of CPAP/BiPAP is associated with the greatest objective improvement.
OBJECTIVES: To investigate interventions used in treating obstructive sleep apnea in neonates and infants and to report their efficacies. DESIGN: Retrospective medical record review. SETTING: Tertiary care children's hospital. PATIENTS: Neonates and infants aged 0 to 12 months at the time of obstructive sleep apnea diagnosis by polysomnography. MAIN OUTCOME MEASURES: Demographic data, comorbidities, polysomnography data, and intervention data. RESULTS: In total, 126 patients (86 [68.3%] male and 40 [31.7%] female) were included in the study. The most common interventions (and the mean age at the time of intervention) were anti-gastroesophageal reflux disease treatment (88 patients [69.8%] at age 7 months), observation (33 patients [26.2%] at age 6 months), supplemental oxygen (31 patients [24.6%] at age 4 months), adenoidectomy (30 patients [23.8%] at age 15 months), other surgical (25 patients [19.8%] at age 7 months), continuous positive airway pressure/bilevel positive airway pressure (CPAP/BiPAP) (18 patients [14.3%] at age 16 months), supraglottoplasty (11 patients [8.7%] at age 6 months), tonsillectomy and adenoidectomy (9 patients [7.1%] at age 24 months), tracheostomy (7 patients [5.6%] at age 10 months), and other nonsurgical (7 patients [5.6%] at age 15 months). Among neonates and infants, nonsurgical interventions were performed in most cases, although those aged 0 to 3 months underwent more surgical interventions (19.7%) than those aged older than 3 to 9 months (11.7%). The mean objective improvement, measured as a percentage decrease in preintervention to postintervention apnea-hypopnea index, was greatest in neonates and infants receiving CPAP/BiPAP, followed by those undergoing tracheostomy. CONCLUSIONS: Anti-gastroesophageal reflux disease treatment is the most common intervention in each age group. Although adenoidectomy is the most common surgical intervention overall, the prevalence increases with age. Supraglottoplasty is the most common surgical intervention in neonates and infants aged 0 to 3 months and offers the greatest objective improvement in this age group. Overall, the use of CPAP/BiPAP is associated with the greatest objective improvement.
Authors: Louella Amos; Olufunke Afolabi-Brown; Dominic Gault; Robin Lloyd; Moshe Y Prero; Carol L Rosen; Raman K Malhotra; Jennifer L Martin; Kannan Ramar; James A Rowley; Fariha Abbasi-Feinberg; R Nisha Aurora; Vishesh K Kapur; Uzma Kazmi; David Kuhlmann; Eric J Olson; Anita V Shelgikar; Sherene M Thomas; Lynn Marie Trotti Journal: J Clin Sleep Med Date: 2022-08-01 Impact factor: 4.324
Authors: Elizabeth A Kiernan; Tao Wang; Amanda M Vanderplow; Sneha Cherukuri; Michael E Cahill; Jyoti J Watters Journal: Front Immunol Date: 2019-07-02 Impact factor: 7.561
Authors: Christopher M Cielo; Patricia Hernandez; Alyssa M Ciampaglia; Melissa S Xanthopoulos; Suzanne E Beck; Ignacio E Tapia Journal: Chest Date: 2020-08-15 Impact factor: 9.410
Authors: Indira Chandrasekar; Mary Anne Tablizo; Manisha Witmans; Jose Maria Cruz; Marcus Cummins; Wendy Estrellado-Cruz Journal: Children (Basel) Date: 2022-03-15
Authors: Prabhjot K Bedi; Maria Luisa Castro-Codesal; Robin Featherstone; Mohammed M AlBalawi; Bashar Alkhaledi; Anita L Kozyrskyj; Carlos Flores-Mir; Joanna E MacLean Journal: Front Pediatr Date: 2018-02-12 Impact factor: 3.418